Literature DB >> 8727076

Potential role of interleukin-1 in the development of bronchopulmonary dysplasia.

M S Rindfleisch1, J D Hasday, V Taciak, K Broderick, R M Viscardi.   

Abstract

Increased activities of inflammatory mediators unopposed by their inhibitors contribute to chronic lung injury and impaired healing in BPD. The deleterious effects of IL-1 beta, a cytokine involved in inflammation and host defense, are blocked by IL-1 receptor antagonist (IL-1Ra). We proposed that an imbalance of IL-1 beta and its inhibitors may contribute to the development of BPD. To determine the relative antigen concentrations of IL-1 beta and IL-1Ra and functional IL-1 activity in lung lavage of infants at risk for BPD, lung lavage was serially obtained from 1 to 28 days from 17 infants with evolving BPD, 13 infants with self-limited RDS, and 6 controls ventilated for nonpulmonary reasons. Overall, there was a high correlation between IL-1 beta antigen concentration and IL-1 activity (r = 0.82, p = 0.0001). There were no significant differences among the groups for lung lavage variables on day 1. However, in infants who developed BPD, IL-1 beta antigen concentration and IL-1 activity increased 16- and 61-fold, respectively, during the first week. IL-1Ra remained relatively unchanged during the first month. IL-1 beta/IL-1Ra antigen ratio was significantly higher on days 5 (median 0.024) and 7 (median 0.025) compared with day 1 (median 0.004), p < 0.05. These results suggest that a relative imbalance of IL-1 beta and IL-1Ra may contribute to prolonged inflammation in BPD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727076     DOI: 10.1089/jir.1996.16.365

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  17 in total

1.  Safety and efficacy of nitric oxide in chronic lung disease.

Authors:  P L Clark; I I Ekekezie; H A Kaftan; C A Castor; W E Truog
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

2.  Establishing the entity of neonatal acute respiratory distress syndrome.

Authors:  Judith Ju-Ming Wong; Bin Huey Quek; Jan Hau Lee
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Pulmonary and systemic inflammatory responses to intra-amniotic IL-1α in fetal sheep.

Authors:  Suhas G Kallapur; Boris W Kramer; Ilias Nitsos; J Jane Pillow; Jennifer J P Collins; Graeme R Polglase; John P Newnham; Alan H Jobe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-10       Impact factor: 5.464

Review 4.  Modulators of inflammation in Bronchopulmonary Dysplasia.

Authors:  Rashmin C Savani
Journal:  Semin Perinatol       Date:  2018-10-02       Impact factor: 3.300

5.  Does the use of 50% oxygen at birth in preterm infants reduce lung injury?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

Review 6.  Perinatal inflammation and lung injury.

Authors:  Rose Marie Viscardi
Journal:  Semin Fetal Neonatal Med       Date:  2011-09-08       Impact factor: 3.926

Review 7.  Cromolyn sodium for the prevention of chronic lung disease in preterm infants.

Authors:  Geraldine Ng; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2017-01-23

8.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia.

Authors:  Jie Liao; Vishal S Kapadia; L Steven Brown; Naeun Cheong; Christopher Longoria; Dan Mija; Mrithyunjay Ramgopal; Julie Mirpuri; Donald C McCurnin; Rashmin C Savani
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919

10.  Maternal IL-1beta production prevents lung injury in a mouse model of bronchopulmonary dysplasia.

Authors:  Erica Bäckström; Urpo Lappalainen; Kristina Bry
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.